Dr. Eric Vallieres – Mesothelioma Doctor – Surgical Director, Thoracic Oncology

Share This:

Swedish Cancer Institute

1221 Madison Street

Suite 400

Seattle, Washington 98104

Phone: 206.215.6800

Fax: 206.215.6801

Email Address: eric.vallieres@swedish.org

Dr. Eric Vallieres is the Surgical Director for Lung Cancer at the Swedish Cancer Institute (SCI), in Seattle, Washington. His specialty is General Thoracic Surgery and his interests include: Esophageal Cancer, Hyperhidrosis, Lung Cancer, Lungs and Esophagus, Mediastinal Pathology, Mesothelioma, and Pleural Diseases. Dr. Vallieres is recognized both nationally and internationally as an authority on and an advocate for the benefits of multimodality therapy for lung cancer patients. Dr. Vallieres is certified in both General Surgery and Thoracic Surgery.

Dr. Vallieres attended the Universite Laval Medical School in Quebec, Canada, from 1978-1982. After receiving his medical degree, he completed his General Surgery Residency at the University of Toronto in Ontario, Canada from 1983-1988. He spent the next year, from 1988-1989, completing his Thoracic Surgery Fellowship, also at the University of Toronto. In 1991, Dr. Vallieres completed his Clinical Fellowship in Thoracic Surgery at the University of Bordeaux, in Bordeaux, France with Professeur Louis Couraud. In 1991, Dr. Vallieres became an Assistant Professor of Surgery at the University of Alberta in Edmonton, Department of Surgery. He was Assistant Professor of Surgery from 1991-1994. In 1994, he took a position as Assistant Professor of Surgery at the University of Ottawa in Ontario in 1994, where he remained until 1996.

Dr. Vallieres came to the states in 1996 and took a position as Associate Professor of Surgery (Department of Surgery) at the University of Washington School of Medicine in Seattle . He was recognized by the University of Washington’s School of Medicine as the Department of Surgery’s “Teacher of the Year” in 1998. He remained with the University of Washington until he was appointed Surgical Director at the Swedish Cancer Institute in 2004.

Dr. Vallieres was an Executive Member of the Lung Site Committee at the National Cancer Institute (NCI) in Canada, Clinical Trials Group, Vice-Chairman of the Lung Committee with the Southwest Oncology Group (SWOG), and surgical principal investigator of the Southwest Oncology Group (SWOG) 9900 Intergroup phase III trial evaluating the role of pre-operative chemotherapy in the management of early stage resectable NSCLC.

Dr. Vallieres’s board certifications include: Fellow of the Royal College of Surgeons of Canada (FRCSC) General Surgery (1988) and FRCSC Thoracic Surgery (1990). He belongs to The Society of Thoracic Surgeons (STS) and the Western Thoracic Surgical Association (WTSA). Dr. Vallieres has received dozens of grants for conducting clinical trials and he has published nearly 150 articles and abstracts.